|
CD47 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.94270000034125E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.7934000031199E-08 |
| Normal-vs-Stage2 |
5.430600E-01 |
| Normal-vs-Stage3 |
1.478190E-03 |
| Normal-vs-Stage4 |
4.804400E-02 |
| Stage1-vs-Stage2 |
4.016400E-02 |
| Stage1-vs-Stage3 |
3.291600E-01 |
| Stage1-vs-Stage4 |
3.899900E-02 |
| Stage2-vs-Stage3 |
2.445600E-01 |
| Stage2-vs-Stage4 |
5.921400E-01 |
| Stage3-vs-Stage4 |
3.449000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.24680000008249E-07 |
| Normal-vs-AfricanAmerican |
6.550000E-02 |
| Normal-vs-Asian |
2.48349999999453E-05 |
| Caucasian-vs-AfricanAmerican |
8.399800E-01 |
| Caucasian-vs-Asian |
2.140200E-01 |
| AfricanAmerican-vs-Asian |
5.260000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.611700E-02 |
| Normal-vs-Female |
5.54919999951053E-08 |
| Male-vs-Female |
1.560400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.04490000044188E-07 |
| Normal-vs-Age(41-60Yrs) |
2.05649999999169E-05 |
| Normal-vs-Age(61-80Yrs) |
3.781000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.612800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.526600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.823250E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.218700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.870130E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.749700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.768200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.135700E-02 |
| Classical-VS-Follicular |
4.59849935907641E-11 |
| Classical-VS-Other |
1.633420E-01 |
| Classical-VS-Normal |
3.79962727947714E-12 |
| Tall-VS-Follicular |
2.243700E-04 |
| Tall-VS-Other |
5.119000E-01 |
| Tall-VS-Normal |
2.319700E-03 |
| Follicular-VS-Other |
4.529000E-01 |
| Follicular-VS-Normal |
1.128780E-01 |
| Other-VS-Normal |
8.189600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.740400E-03 |
| Normal-vs-N1 |
3.195400E-03 |
| N0-vs-N1 |
5.101600E-01 |
|
|
